Compare Summit Therapeutics Inc (SMMT) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Utilities Select Sector SPDR Fund — how do they compare? Summit Therapeutics Inc trades at $17.6 (market cap $13.71B), while Utilities Select Sector SPDR Fund trades at $41.37 (market cap $23.60B). The key difference: Utilities Select Sector SPDR Fund is the larger of the two by market cap, and Summit Therapeutics Inc is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Summit Therapeutics Inc for 16 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| SMMT | XLU | |
|---|---|---|
Market Cap | $13.71B | $23.60B |
Volume | 6,173,057 | 28,758,237 |
Sector | Health | — |
52-Week High | $26.38 | $47.73 |
52-Week Low | $12.43 | $39.25 |
Typical Hold Time | 16 Days | 80 Days |
Enterprise Value | $13.04B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Summit Therapeutics (SMMT) trades at $17.59, down 2.01% on the day, amid mixed earnings performance but strong analyst support with a consensus price target of $29.33. The stock shows a bullish technical signal from moving averages, with key support at $17 and resistance at $18. Recent news highlights a major $2 billion strategic investment from AstraZeneca and expanded clinical collaborations, boosting investor optimism despite current negative profitability metrics.
The outlook for SMMT is heavily driven by clinical progress and partnerships, offering significant upside if drug trials succeed, but carries high risk due to substantial losses, negative cash flow from operations, and reliance on positive trial outcomes. Investors should weigh the potential rewards against the company's current financial health and execution risks.
XLU trades at $41.39, up 0.58% today, with technical indicators showing a mixed but overall bullish signal. The ETF recently hit 52-week lows around $39.13 amid sector-wide pressure from rising interest rates. Moving averages suggest bullish momentum, while oscillators remain neutral with RSI at 54.66 indicating balanced momentum. Recent news highlights utility stocks as oversold, creating potential buying opportunities for defensive investors.
The outlook remains cautious due to interest rate sensitivity, but current levels may offer value for long-term investors seeking defensive exposure. Key risks include further rate hikes and regulatory challenges, while potential catalysts include AI-driven power demand and defensive positioning during market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
